Clinical Trial Update: Adiponectin in Obese Women With T2DN and Effects by RAS Blocker [NA]

View source ↗

Summary

This clinical trial update notes completion of a study evaluating adiponectin in obese women with type 2 diabetes and diabetic nephropathy, examining effects by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Angiotensin II Type 1 Receptor Blockers (angiotensin II receptor blocker)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Obese, Type 2 Diabetes | NA | Status: COMPLETED